Trial · NCT03100942
Results by group20
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 20
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants Fulfilling Protocol-Specified Response Criteria at Week 12, as Compared to Baseline | Lanraplenib | 42.9 | 95% Confidence Interval 25.0 to 60.7 | percentage of participants | |
| Percentage of Participants Fulfilling Protocol-Specified Response Criteria at Week 12, as Compared to Baseline | Filgotinib | 43.2 | 95% Confidence Interval 25.9 to 60.6 | percentage of participants | |
| Percentage of Participants Fulfilling Protocol-Specified Response Criteria at Week 12, as Compared to Baseline | Tirabrutinib | 35.1 | 95% Confidence Interval 18.4 to 51.9 | percentage of participants | |
| Percentage of Participants Fulfilling Protocol-Specified Response Criteria at Week 12, as Compared to Baseline | Placebo | 26.5 | 95% Confidence Interval 10.2 to 42.8 | percentage of participants | |
| Change From Baseline in European League Against Rheumatism (EULAR) Sjogren's Syndrome Disease Activity Index (ESSDAI) at Week 12 | Lanraplenib | -2.5 | Standard Error 0.76 | score on a scale | |
| Change From Baseline in European League Against Rheumatism (EULAR) Sjogren's Syndrome Disease Activity Index (ESSDAI) at Week 12 | Filgotinib | -4.7 | Standard Error 0.72 | score on a scale | |
| Change From Baseline in European League Against Rheumatism (EULAR) Sjogren's Syndrome Disease Activity Index (ESSDAI) at Week 12 | Tirabrutinib | -3.2 | Standard Error 0.73 | score on a scale | |
| Change From Baseline in European League Against Rheumatism (EULAR) Sjogren's Syndrome Disease Activity Index (ESSDAI) at Week 12 | Placebo | -3.9 | Standard Error 0.76 | score on a scale | |
| Change From Baseline in EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI) at Week 12 | Lanraplenib | -1.0 | Standard Error 0.34 | score on a scale | |
| Change From Baseline in EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI) at Week 12 | Filgotinib | -1.4 | Standard Error 0.33 | score on a scale | |
| Change From Baseline in EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI) at Week 12 | Tirabrutinib | -1.4 | Standard Error 0.33 | score on a scale | |
| Change From Baseline in EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI) at Week 12 | Placebo | -1.0 | Standard Error 0.34 | score on a scale | |
| Change From Baseline in ESSDAI at Week 24 | Lanraplenib | -4.3 | Standard Error 0.81 | score on a scale | |
| Change From Baseline in ESSDAI at Week 24 | Filgotinib | -5.4 | Standard Error 0.75 | score on a scale | |
| Change From Baseline in ESSDAI at Week 24 | Tirabrutinib | -4.0 | Standard Error 0.75 | score on a scale | |
| Change From Baseline in ESSDAI at Week 24 | Placebo | -4.2 | Standard Error 0.78 | score on a scale | |
| Change From Baseline in ESSPRI at Week 24 | Lanraplenib | -1.1 | Standard Error 0.34 | score on a scale | |
| Change From Baseline in ESSPRI at Week 24 | Filgotinib | -0.8 | Standard Error 0.31 | score on a scale | |
| Change From Baseline in ESSPRI at Week 24 | Tirabrutinib | -1.2 | Standard Error 0.31 | score on a scale | |
| Change From Baseline in ESSPRI at Week 24 | Placebo | -0.9 | Standard Error 0.33 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03100942/results